New Research by VGTI Florida Science Director Demonstrates How HIV Disables the Immune System (AEGiS.org) - New Research by VGTI Florida Science Director Demonstrates How HIV Disables the Immune System
Business Wire - March 16, 2010
http://www.aegis.org/news/bw/2010/BW100315.html

Research Helps Focus Future Studies to Specifically Target the Series of Cellular Interactions That Cause the Body to Drop Its Guard
PORT ST. LUCIE, Fla. - New research conducted by the scientific director for VGTI Florida and his colleagues at the University of Montreal, in collaboration with scientists from the NIH and the McGill University Hospital center, may soon lead to an expansion of the drug arsenal used to fight HIV. The research sheds new light on how HIV gradually weakens the body's immune system and highlights the need for new research into therapies that will target the chain of events that cause the progression of the disease.
The study, published in the journal Nature Medicine, describes the pivotal role of two molecules, PD-1 and IL-10, in impairing the function of disease-fighting T-cells known as CD4 T-cells û a phenomenon that weakens the body's immune system.
Specifically, the researchers found that when HIV invades the body, bacterial products are released from the gut and white blood cells respond by releasing a protein on the surface of the cell called PD-1. Heightened levels of PD-1 lead to the activation of a gene that produces another protein called IL-10. Both of these proteins (PD-1 and IL-10) are known to appear at increased levels during HIV infection.
"We are the first to show that these two molecules work together to shut down the function of CD4 T-cells in HIV patients. This in turn, may lead to paralysis of the immune system and an accelerated disease progression," said Dr. Rafick-Pierre Sekaly, scientific director of VGTI Florida, a professor at the University of Montreal and researcher at the Research Center of the University of Montreal Hospital Center.
"Our results suggest that it is important to block both IL-10 and PD-1 interactions to restore the immune response during HIV infection," said Dr. Sekaly. "We believe that immunotherapies that target PD-1 and IL-10 should be part of the arsenal used to restore immune function in HIV-infected subjects."
About the study:
The article "PD-1 Induced IL-10 Production by Monocytes Impairs CD4 T-Cell Activation during HIV Infection," published in Nature, was authored by Elias A. Said, Franck P. Dupuy, Lydie Trautmann, Yuwei Zhang, Yu Shi, Mohamed El-Far, Brenna J. Hill, Alessandra Noto, Petronela Ancuta, Yoav Peretz, Simone G. Fonseca, Julien Van Grevenynghe, Mohamed R. Boulassel, Julie Bruneau, Naglaa H. Shoukry, Jean-Pierre Routy, Daniel C. Douek, Elias K. Haddad, and Rafick P. Sekaly.
About VGTI Florida:
VGTI Florida is the Florida-funded expansion of Oregon Health & Science University's highly successful Vaccine and Gene Therapy Institute. Research at the facility will focus on vaccine development with a special focus on vaccines and therapeutics that protect the aging population, which is the most vulnerable to disease.
Contacts
For VGTI Florida
Ryan Banfill, 850-222-1996
100316 BW100315

Copyright © 2010 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2010. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2010. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. [AEGiS]